Table 1 Demographic data of the study population
All patients (n = 635) | CCPR (n = 523) | ECPR (n = 112) | p value | |
|---|---|---|---|---|
Age, years | 62 ± 16 | 65 ± 16 | 54 ± 16 | < 0.001 |
Male, n (%) | 419 (66) | 336 (64) | 83 (74) | 0.04 |
Witnessed CA, n (%) | 480 (78) | 387 (77) | 93 (83) | 0.04 |
Bystander CPR, n (%) | 423 (68) | 346 (68) | 77 (69) | 0.60 |
ROSC, n (%) | 512 (81) | 404 (77) | 108 (96) | < 0.001 |
Time to ROSC, min | 24 ± 21 | 18 ± 14 | 48 ± 27 | < 0.001 |
Out-of-hospital CA | 351 (55) | 281 (54) | 70 (63) | 0.09 |
Non-cardiac origin CA | 325 (51) | 283 (54) | 42 (38) | 0.001 |
VF/VT, n (%) | 176 (28) | 141 (27) | 35 (32) | 0.36 |
Chronic heart failure, n (%) | 139 (22) | 114 (22) | 25 (22) | 0.89 |
Hypertension, n (%) | 285 (45) | 245 (47) | 40 (36) | 0.03 |
Coronary artery disease, n (%) | 220 (35) | 179 (34) | 41 (37) | 0.63 |
Diabetes, n (%) | 137 (22) | 123 (24) | 14 (13) | 0.01 |
COPD/asthma, n (%) | 131 (21) | 119 (23) | 12 (11) | 0.004 |
Neurological disease, n (%) | 102 (16) | 95 (18) | 7 (6) | 0.002 |
Chronic renal disease, n (%) | 102 (16) | 88 (17) | 14 (13) | 0.26 |
Liver cirrhosis, n (%) | 43 (7) | 37 (7) | 6 (5) | 0.52 |
TTM, n (%) | 339 (54) | 251 (48) | 88 (79) | < 0.001 |
MV, n (%) | 635 (100) | 523 (100) | 112 (100) | 1.00 |
ICU stay, days | 5 [1–6] | 4 [1–90] | 8 [1–90] | < 0.001 |
ICU survival, n (%) | 164 (26) | 140 (27) | 24 (21) | 0.28 |
3-month favorable neurological outcome, n (%) | 111 (18) | 106 (20) | 19 (16) | 0.48 |